A. Lavolé

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster et al. · The Lancet · 2011 · 575 citations

Medicine, Geriatric Medicine, Oncology +10

Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia

Vincent Cottin, Thierry Chinet, A. Lavolé et al. · Medicine · 2007 · 215 citations · Full text

Medicine, Anatomy, Pathology +13

Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort

Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier et al. · Clinical Infectious Diseases · 2013 · 122 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Six-month prognosis of patients with lung cancer admitted to the intensive care unit

Sébastien Roques, Antoine Parrot, A. Lavolé et al. · Intensive Care Medicine · 2009 · 121 citations

Medicine, Oncology, Critical Care Medicine +12

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

Marie Wislez, Julien Mazières, A. Lavolé et al. · Journal for ImmunoTherapy of Cancer · 2022 · 114 citations · Full text

Medicine, Oncology, Chemotherapy +14